Radiolabeled nano-peptides show specificity for an animal model of human PC3 prostate cancer cells

This publication has 30 references indexed in Scilit:

• Prevention Strategies in Prostate Cancer
  Current Oncology, 2010
• In Vivo Delivery of Antisense MORF Oligomer by MORF/Carrier Streptavidin Nanoparticles
  Cancer Biotherapy and Radiopharmaceuticals, 2009
• ¹⁸F, ⁶⁴Cu, and ⁶⁸Ga Labeled RGD-Bombesin Heterodimeric Peptides for PET Imaging of Breast Cancer
  Bioconjugate Chemistry, 2009
• An improved synthesis of NHS-MAG3 for conjugation and radiolabeling of biomolecules with 99mTc at room temperature
  Nature Protocols, 2007
• MicroPET Imaging of Breast Cancer Using Radiolabeled Bombesin Analogs Targeting the Gastrin-releasing Peptide Receptor
  Breast Cancer Research and Treatment, 2006
• Further investigations of morpholino pretargeting in mice—establishing quantitative relations in tumor
  European Journal of Nuclear Medicine and Molecular Imaging, 2005
• Species differences of bombesin analog interactions with GRP-R define the choice of animal models in the development of GRP-R-targeting drugs.
  2005
• Radiochemical Investigations of ^99mTc−N₃S-X-BBN[7−14]NH₂: An in Vitro/in Vivo Structure−Activity Relationship Study Where X = 0-, 3-, 5-, 8-, and 11-Carbon Tethering Moieties
  Bioconjugate Chemistry, 2002
• A ^99mTc(I)-Postlabeled High Affinity Bombesin Analogue as a Potential Tumor Imaging Agent
  Bioconjugate Chemistry, 2002
• Tumor pretargeting in mice using (99m)Tc-labeled morpholino, a DNA analog.
  2002